The first estimate of US prevalence for<unk> s as a group was published in 1997 by Jacobson, et al. They reported US prevalence to be around 9 million, applying prevalence estimates for 24 diseases to a US population of 279 million. Jacobson's work was updated by Hayter & Cook in 2012. This study used Witebsky's postulates, as revised by Rose & Bona, to extend the list to 81 diseases and estimated overall cumulative US prevalence for the 81<unk> s at 5.0%, with 3.0% for males and 7.1% for females. The estimated community prevalence, which takes into account the observation that many people have more than one<unk> , was 4.5% overall, with 2.7% for males and 6.4% for females. National Health and Nutrition Examination Surveys conducted in the US from the 1980s to present day, have shown an increase of antinuclear antibodies, a common biomarker for<unk> s. This shows that there has been an increase in the prevalence of<unk> s in recent years pointing to a stronger influence of environment factors as a risk factor for<unk> s.
Autoimmune disease
Adhesive capsulitis of the shoulder
Neurodegenerative disease
Degenerative disease
Viral disease
Neuromuscular disease
Autoinflammatory diseases
Immune disorder